Home | Welcome to Contract Pharma   
Last Updated Saturday, April 19 2014
Print

Topics - Business Trends


Refine by Date:
From: To:
By Kristin Brooks
Published March 6, 2014
Reveals increased technology, partnerships, and open innovation practices Read More »
By Gil Roth
Published February 26, 2014
Exchange of ideas can lead to mutually beneficial linkages Read More »
By Gil Roth
Published February 18, 2014
$25 bil. purchase will create $15 bil. company Read More »
By Gil Roth
Published February 12, 2014
Focuses on three themes, streamlines informatics offerings Read More »
By Gil Roth
Published February 11, 2014
Biannual event attracts scientists, executives Read More »
By Gil Roth
Published February 6, 2014
Generic exclusivity boosts 4Q revenues Read More »
By Gil Roth
Published February 6, 2014
Diabetes, Genzyme, Generics key drivers Read More »
By Gil Roth
Published February 6, 2014
Generics drive sales down, more layoffs planned Read More »
By Gil Roth
Published February 5, 2014
Growth pushed by Late-Stage Development segment Read More »
By Gil Roth
Published February 5, 2014
Botox, eye care drugs fuel growth Read More »
By Gil Roth
Published February 5, 2014
Pharma & Vaccines up 6% in 4Q13 Read More »
By Gil Roth
Published February 5, 2014
Stribild, Complera/Eviplera drive growth Read More »
By Gil Roth
Published February 5, 2014
Singulair, other patent expirations weigh on revenues Read More »
By Andrew Badrot, CMS Pharma
Published January 30, 2014
DSM & Patheon unlock value through a creative merger Read More »
By Gil Roth
Published January 30, 2014
Oncology drugs fuel growth Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On